Continence training of children with neurogenic bladder dysfunction.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002217:Carbachol / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003248:Constipation / Q000150:complications; D003975:Diazepam / Q000627:therapeutic use; D004809:Ephedrine / Q000627:therapeutic use; D005260:Female; D006760:Hospitalization; D006801:Humans; D008297:Male; D009042:Motivation; D010264:Paraplegia / Q000150:complications; D011379:Prognosis; D012447:Sacrum / Q000002:abnormalities; D012737:Sex Factors; D016135:Spinal Dysraphism / Q000150:complications; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D014547:Urinary Diversion; D014549:Urinary Incontinence / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D014552:Urinary Tract Infections / Q000150:complications
D002217:Carbachol; D004809:Ephedrine; D003975:Diazepam